Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cytotechnology|November 13, 2008
The role of recombinant proteins in the development of serum-free mediaJoanne Keenan, Dermot Pearson, Martin Clynes
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Generation of lung cancer cell line variants by drug selection or cloningLaura Breen, Joanne Keenan, Martin Clynes
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 3, 2008
Development of taxane resistance in a panel of human lung cancer cell linesLaura Breen, Lisa Murphy, Joanne Keenan, et al.
Cytotechnology|November 13, 2008
Evaluation of recombinant human transferrin (DeltaFerrin(TM)) as an iron chelator in serum-free media for mammalian cell cultureJoanne Keenan, Dermot Pearson, Lorraine O'Driscoll, et al.
Microbes and Infection|June 20, 2006
Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptidesDavid Bergin, Lisa Murphy, Joanne Keenan, et al.
Proteomics|February 27, 2009
Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell lineJoanne Keenan, Lisa Murphy, Michael Henry, et al.
In Vitro Cellular & Developmental Biology. Animal|February 25, 2019
Copper-induced non-monotonic dose response in Caco-2 cellsCharles O'Doherty, Joanne Keenan, Karina Horgan, et al.
Nutrients|January 10, 2026
The Antagonistic Influence of Phytic Acid on Zinc Absorption: An <i>In Vitro</i> Comparison of Inorganic and Chelated Trace Mineral SourcesNiamh Rock, Martin Clynes, Karina Horgan, et al.
Human Cell|July 6, 2022
The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survivalSophie Rae, Cathy Spillane, Gordon Blackshields, et al.
Experimental Cell Research|January 28, 2012
Olfactomedin III expression contributes to anoikis-resistance in clonal variants of a human lung squamous carcinoma cell lineJoanne Keenan, Helena Joyce, Sinead Aherne, et al.
Pageof 3